DIA
AMED

Denver Investment Advisors’s Amedisys AMED Stock Holding History

Denver Investment Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$839K Buy
13,902
+852
+7% +$48.5K 0.04% 252
2017
Q4 		$688K Buy
13,050
+4,645
+55% +$245K 0.03% 274
2017
Q3 		$470K Buy
8,405
+20
+0.2% +$1.06K 0.02% 330
2017
Q2 		$527K Sell
8,385
-10,720
-56% -$624K 0.02% 313
2017
Q1 		$976K Buy
19,105
+4,220
+28% +$201K 0.04% 241
2016
Q4 		$635K Buy
+14,885
New +$633K 0.03% 304

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Denver Investment Advisors's AMED Position: Q1 2018 in Review

Denver Investment Advisors increased its Amedisys (AMED) stake by 6.5% in Q1 2018, buying an estimated $48.5K and bringing the position to 13,902 shares worth $839K. The position accounts for 0.04% of the portfolio, ranked #252.

Denver Investment Advisors first reported a position in AMED in Q4 2016 and has held it in 6 quarters since. The position peaked at $976K in Q1 2017. 194 funds tracked by Wall St. Rank hold AMED as of Q1 2018.

  • Denver Investment Advisors held 13,902 shares of Amedisys worth $839K as of Q1 2018.
  • Denver Investment Advisors bought 852 Amedisys shares in Q1 2018, an estimated $48.5K.
  • Amedisys made up 0.04% of Denver Investment Advisors's portfolio in Q1 2018, its #252 holding.
  • Denver Investment Advisors first reported a position in Amedisys in Q4 2016 and has held it in 6 quarters since.
  • Denver Investment Advisors's Amedisys position peaked at $976K in Q1 2017.
  • 194 funds tracked by Wall St. Rank held Amedisys as of Q1 2018.

Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.